December 19, 2016
Chugai Pharmaceutical said on December 16 that it has filed a public knowledge-based application for a new pediatric dosage of its anti-influenza drug Tamiflu Dry Syrup 3% (oseltamivir). The new dosage was filed for the treatment, and not prevention, of...read more